Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04010357
Title Targeted Therapy With CDK4/6 Inhibitors in Chemo-Refractory, Rb Wild-Type Extensive SCLC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Case Comprehensive Cancer Center
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST